HARMONY 3: 104 week efficacy of albiglutide compared to sitagliptin and glimepiride in patients with type 2 diabetes mellitus on metformin

被引：0
|
作者：
Johnson, S. [1 ]
Ahren, B. [2 ]
Stewart, M.
Cirkel, D. [3 ]
Yang, F.
Perry, C.
机构：
[1] GlaxoSmithKline, Res Triangle Pk, NC USA
[2] Lund Univ, S-22100 Lund, Sweden
[3] GlaxoSmithKline, Stevenage, Herts, England
来源：
DIABETOLOGIA | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5
引用
收藏
页码：S8 / S9
页数：2
相关论文
共 50 条
  • [21] Safety and efficacy of ertugliflozin compared with glimepiride after 104 weeks in patients with type 2 diabetes inadequately controlled on metformin: VERTIS SU extension
    Hollander, P.
    Liu, J.
    Hill, J.
    Johnson, J.
    Jiang, Z. W.
    Wang, D.
    Golm, G.
    Huyck, S.
    Terra, S.
    Mancuso, J. P.
    Engel, S. S.
    Lauring, B.
    DIABETOLOGIA, 2018, 61 : S304 - S304
  • [22] HARMONY 1 results at week 52 primary endpoint: once-weekly albiglutide vs placebo in patients with type 2 diabetes mellitus not controlled on pioglitazone ± metformin
    Reusch, J.
    Stewart, M.
    Perkins, C.
    Ordronneau, P.
    Ye, J.
    Perry, C.
    Reinhardt, R.
    Bode, B.
    DIABETOLOGIA, 2013, 56 : S359 - S360
  • [23] Efficacy and safety of titrated canagliflozin in patients with type 2 diabetes mellitus inadequately controlled on metformin and sitagliptin
    Rodbard, H. W.
    Seufert, J.
    Aggarwal, N.
    Cao, A.
    Fung, A.
    Pfeifer, M.
    Alba, M.
    DIABETES OBESITY & METABOLISM, 2016, 18 (08): : 812 - 819
  • [24] Harmony 1 Year 3 Results: Albiglutide vs. Placebo in Patients with Type 2 Diabetes Mellitus Not Controlled on Pioglitazone (Pio) ± Metformin (Met)
    Bode, Bruce W.
    Stewart, Murray
    Cirkel, Deborah
    Yang, Fred
    Perry, Caroline
    Perkins, Christopher
    Ambery, Philip
    DIABETES, 2014, 63 : A246 - A246
  • [25] Efficacy and safety of sitagliptin/metformin fixed-dose combination compared with glimepiride in patients with type 2 diabetes: A multicenter randomized double-blind study
    Kim, Sang Soo
    Kim, In Joo
    Lee, Kwang Jae
    Park, Jeong Hyun
    Kim, Young Il
    Lee, Young Sil
    Chung, Sung Chang
    Lee, Sang Jin
    JOURNAL OF DIABETES, 2017, 9 (04) : 412 - 422
  • [26] The efficacy and safety of adding either vildagliptin or glimepiride to ongoing metformin therapy in patients with type 2 diabetes mellitus
    Kim, Gyuri
    Oh, Sewon
    Jin, Sang-Man
    Hur, Kyu Yeon
    Kim, Jae Hyeon
    Lee, Moon-Kyu
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (12) : 1179 - 1186
  • [27] Achievement of weight loss with canagliflozin, sitagliptin and glimepiride in combination with metformin or metformin plus sulfonylurea in patients with Type 2 diabetes
    Stein, L.
    Thompson, G.
    Diels, J.
    Thilakarathne, P.
    Girod, I.
    DIABETIC MEDICINE, 2014, 31 : 145 - 145
  • [28] Comparison of the efficacy of sitagliptin and glimepiride dose-up in Japanese patients with type 2 diabetes poorly controlled by sitagliptin and glimepiride in combination
    Shimoda, Seiya
    Iwashita, Shinsuke
    Sekigami, Taiji
    Furukawa, Noboru
    Matsuo, Yasuto
    Ichimori, Shinji
    Goto, Rieko
    Maeda, Takako
    Watanabe, Eiichiro
    Kondo, Tatsuya
    Matsumura, Takeshi
    Motoshima, Hiroyuki
    Nishida, Kenro
    Araki, Eiichi
    JOURNAL OF DIABETES INVESTIGATION, 2014, 5 (03) : 320 - 326
  • [29] Harmony 5-year 3 Results: albiglutide vs placebo and vs pioglitazone in triple therapy (background metformin and glimepiride) in people with type 2 diabetes
    Shamanna, P.
    Home, P.
    Stewart, M. W.
    Mallory, J. M.
    Miller, D. M.
    Perry, C. R.
    Carr, M. C.
    DIABETOLOGIA, 2014, 57 : S340 - S340
  • [30] Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy
    Ferrannini, E.
    Fonseca, V.
    Zinman, B.
    Matthews, D.
    Ahren, B.
    Byiers, S.
    Shao, Q.
    Dejager, S.
    DIABETES OBESITY & METABOLISM, 2009, 11 (02): : 157 - 166
12345